APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Medical Imaging Software for Cardiovascular Disease

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global AI Medical Imaging Software for Cardiovascular Disease Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

5 June 2026196 pages

Choose your research edition.

Industry ResearchAI Medical Imaging Software for Cardiovascular Disease Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Medical Imaging Software for Cardiovascular Disease Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal AI Medical Imaging Software for Cardiovascular Disease Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Medical Imaging Software for Cardiovascular Disease Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Medical Imaging Software for Cardiovascular Disease Market Analysis and Forecast 2026-2032227 pages · $4,950 USD

Market perspective

The global AI Medical Imaging Software for Cardiovascular Disease market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for AI Medical Imaging Software for Cardiovascular Disease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Medical Imaging Software for Cardiovascular Disease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Medical Imaging Software for Cardiovascular Disease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for AI Medical Imaging Software for Cardiovascular Disease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of AI Medical Imaging Software for Cardiovascular Disease include Siemens, United-Imaging, Deepwise, Atrui Technology, Lepu Medical, Keya Medical, RaysightMed, Shukun Technology and Infervision Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global AI Medical Imaging Software for Cardiovascular Disease market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Medical Imaging Software for Cardiovascular Disease and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Medical Imaging Software for Cardiovascular Disease revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AI Medical Imaging Software for Cardiovascular Disease market size, projected growth trends, production technologies, key applications, and end-use industries.

AI Medical Imaging Software for Cardiovascular Disease Segment by Company

Siemens

United-Imaging

Deepwise

Atrui Technology

Lepu Medical

Keya Medical

RaysightMed

Shukun Technology

Infervision Medical

Yizhun Intelligent

Pulse Medical

Fosun Aitrox

Edan Instruments

Thoth Medical

Nalong Health

AI Medical Imaging Software for Cardiovascular Disease Segment by Type

Cloud-Based

On-Premise

AI Medical Imaging Software for Cardiovascular Disease Segment by Application

Hospital

Clinic

AI Medical Imaging Software for Cardiovascular Disease Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Medical Imaging Software for Cardiovascular Disease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Medical Imaging Software for Cardiovascular Disease and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Medical Imaging Software for Cardiovascular Disease.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AI Medical Imaging Software for Cardiovascular Disease in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Medical Imaging Software for Cardiovascular Disease industry.

Chapter 3: Detailed analysis of AI Medical Imaging Software for Cardiovascular Disease companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Medical Imaging Software for Cardiovascular Diseaserevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Medical Imaging Software for Cardiovascular Disease Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Cloud-Based Table 3. Key Players of On-Premise Table 4. Global AI Medical Imaging Software for Cardiovascular Disease Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Global AI Medical Imaging Software for Cardiovascular Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global AI Medical Imaging Software for Cardiovascular Disease Market Size by Region (2021-2026) & (US$ Million) Table 9. Global AI Medical Imaging Software for Cardiovascular Disease Market Share by Region (2021-2026) Table 10. Global AI Medical Imaging Software for Cardiovascular Disease Market Size by Region (2027-2032) & (US$ Million) Table 11. Global AI Medical Imaging Software for Cardiovascular Disease Market Share by Region (2027-2032) Table 12. AI Medical Imaging Software for Cardiovascular Disease Industry Trends Table 13. AI Medical Imaging Software for Cardiovascular Disease Industry Drivers Table 14. AI Medical Imaging Software for Cardiovascular Disease Industry Opportunities and Challenges Table 15. AI Medical Imaging Software for Cardiovascular Disease Industry Restraints Table 16. Global AI Medical Imaging Software for Cardiovascular Disease Revenue by Company (US$ Million) & (2021-2026) Table 17. Global AI Medical Imaging Software for Cardiovascular Disease Revenue Market Share by Company (2021-2026) Table 18. Global AI Medical Imaging Software for Cardiovascular Disease Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global AI Medical Imaging Software for Cardiovascular Disease Key Company Head Office and Area Served Table 20. Global AI Medical Imaging Software for Cardiovascular Disease Company, Product Type & Application Table 21. Global AI Medical Imaging Software for Cardiovascular Disease Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global AI Medical Imaging Software for Cardiovascular Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global AI Medical Imaging Software for Cardiovascular Disease Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2021-2026) & (US$ Million) Table 26. Global AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2027-2032) & (US$ Million) Table 27. Global AI Medical Imaging Software for Cardiovascular Disease Revenue Market Share by Type (2021-2026) Table 28. Global AI Medical Imaging Software for Cardiovascular Disease Revenue Market Share by Type (2027-2032) Table 29. Global AI Medical Imaging Software for Cardiovascular Disease Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2021-2026) & (US$ Million) Table 31. Global AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2027-2032) & (US$ Million) Table 32. Global AI Medical Imaging Software for Cardiovascular Disease Revenue Market Share by Application (2021-2026) Table 33. Global AI Medical Imaging Software for Cardiovascular Disease Revenue Market Share by Application (2027-2032) Table 34. Siemens Company Information Table 35. Siemens Business Overview Table 36. Siemens AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Siemens AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 38. Siemens Recent Development Table 39. United-Imaging Company Information Table 40. United-Imaging Business Overview Table 41. United-Imaging AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. United-Imaging AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 43. United-Imaging Recent Development Table 44. Deepwise Company Information Table 45. Deepwise Business Overview Table 46. Deepwise AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Deepwise AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 48. Deepwise Recent Development Table 49. Atrui Technology Company Information Table 50. Atrui Technology Business Overview Table 51. Atrui Technology AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Atrui Technology AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 53. Atrui Technology Recent Development Table 54. Lepu Medical Company Information Table 55. Lepu Medical Business Overview Table 56. Lepu Medical AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Lepu Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 58. Lepu Medical Recent Development Table 59. Keya Medical Company Information Table 60. Keya Medical Business Overview Table 61. Keya Medical AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Keya Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 63. Keya Medical Recent Development Table 64. RaysightMed Company Information Table 65. RaysightMed Business Overview Table 66. RaysightMed AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. RaysightMed AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 68. RaysightMed Recent Development Table 69. Shukun Technology Company Information Table 70. Shukun Technology Business Overview Table 71. Shukun Technology AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Shukun Technology AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 73. Shukun Technology Recent Development Table 74. Infervision Medical Company Information Table 75. Infervision Medical Business Overview Table 76. Infervision Medical AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Infervision Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 78. Infervision Medical Recent Development Table 79. Yizhun Intelligent Company Information Table 80. Yizhun Intelligent Business Overview Table 81. Yizhun Intelligent AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Yizhun Intelligent AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 83. Yizhun Intelligent Recent Development Table 84. Pulse Medical Company Information Table 85. Pulse Medical Business Overview Table 86. Pulse Medical AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Pulse Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 88. Pulse Medical Recent Development Table 89. Fosun Aitrox Company Information Table 90. Fosun Aitrox Business Overview Table 91. Fosun Aitrox AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Fosun Aitrox AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 93. Fosun Aitrox Recent Development Table 94. Edan Instruments Company Information Table 95. Edan Instruments Business Overview Table 96. Edan Instruments AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Edan Instruments AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 98. Edan Instruments Recent Development Table 99. Thoth Medical Company Information Table 100. Thoth Medical Business Overview Table 101. Thoth Medical AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Thoth Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 103. Thoth Medical Recent Development Table 104. Nalong Health Company Information Table 105. Nalong Health Business Overview Table 106. Nalong Health AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Nalong Health AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 108. Nalong Health Recent Development Table 109. North America AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2021-2026) & (US$ Million) Table 110. North America AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2027-2032) & (US$ Million) Table 111. North America AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2021-2026) & (US$ Million) Table 112. North America AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2027-2032) & (US$ Million) Table 113. North America AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021-2026) Table 115. North America AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2027-2032) Table 116. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2021-2026) & (US$ Million) Table 117. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2027-2032) & (US$ Million) Table 118. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2021-2026) & (US$ Million) Table 119. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2027-2032) & (US$ Million) Table 120. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021-2026) Table 122. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2027-2032) Table 123. China AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2021-2026) & (US$ Million) Table 124. China AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2027-2032) & (US$ Million) Table 125. China AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2021-2026) & (US$ Million) Table 126. China AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2027-2032) & (US$ Million) Table 127. Asia AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2021-2026) & (US$ Million) Table 128. Asia AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2027-2032) & (US$ Million) Table 129. Asia AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2021-2026) & (US$ Million) Table 130. Asia AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2027-2032) & (US$ Million) Table 131. Asia AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Asia AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021-2026) Table 133. Asia AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2027-2032) Table 134. South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2021-2026) & (US$ Million) Table 135. South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2027-2032) & (US$ Million) Table 136. South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2021-2026) & (US$ Million) Table 137. South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2027-2032) & (US$ Million) Table 138. South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021-2026) Table 140. South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2027-2032) Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. AI Medical Imaging Software for Cardiovascular Disease Product Image Figure 2. Global AI Medical Imaging Software for Cardiovascular Disease Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global AI Medical Imaging Software for Cardiovascular Disease Market Share by Type: 2025 VS 2032 Figure 4. Cloud-Based Image Figure 5. On-Premise Image Figure 6. Global AI Medical Imaging Software for Cardiovascular Disease Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global AI Medical Imaging Software for Cardiovascular Disease Market Share by Application: 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global AI Medical Imaging Software for Cardiovascular Disease Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 12. Global AI Medical Imaging Software for Cardiovascular Disease Market Share by Region: 2025 VS 2032 Figure 13. Years Considered Figure 14. Global AI Medical Imaging Software for Cardiovascular Disease Market Share by Players in 2025 Figure 15. Global Top 5 and 10 AI Medical Imaging Software for Cardiovascular Disease Players Market Share by Revenue in 2025 Figure 16. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global AI Medical Imaging Software for Cardiovascular Disease Revenue Market Share by Type (2021-2032) Figure 19. Global AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global AI Medical Imaging Software for Cardiovascular Disease Revenue Market Share by Application (2021-2032) Figure 21. North America AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 22. North America AI Medical Imaging Software for Cardiovascular Disease Market Share by Type (2021-2032) Figure 23. North America AI Medical Imaging Software for Cardiovascular Disease Market Share by Application (2021-2032) Figure 24. North America AI Medical Imaging Software for Cardiovascular Disease Market Share by Country (2021-2032) Figure 25. United States AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 26. Canada AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 27. Mexico AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 28. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 29. Europe AI Medical Imaging Software for Cardiovascular Disease Market Share by Type (2021-2032) Figure 30. Europe AI Medical Imaging Software for Cardiovascular Disease Market Share by Application (2021-2032) Figure 31. Europe AI Medical Imaging Software for Cardiovascular Disease Market Share by Country (2021-2032) Figure 32. Germany AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 33. France AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 34. U.K. AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 35. Italy AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 36. Russia AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 37. Nordic Countries AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 38. China AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 39. China AI Medical Imaging Software for Cardiovascular Disease Market Share by Type (2021-2032) Figure 40. China AI Medical Imaging Software for Cardiovascular Disease Market Share by Application (2021-2032) Figure 41. Asia AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 42. Asia AI Medical Imaging Software for Cardiovascular Disease Market Share by Type (2021-2032) Figure 43. Asia AI Medical Imaging Software for Cardiovascular Disease Market Share by Application (2021-2032) Figure 44. Asia AI Medical Imaging Software for Cardiovascular Disease Market Share by Country (2021-2032) Figure 45. Japan AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 46. South Korea AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 47. Taiwan AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 48. Southeast Asia AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 49. India AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 50. Australia AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 51. South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Share by Type (2021-2032) Figure 53. South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Share by Application (2021-2032) Figure 54. South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Share by Country (2021-2032) Figure 55. Brazil AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 56. South Africa AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 57. Saudi Arabia AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 58. Turkey AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 59. Argentina AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 60. UAE AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 61. Egypt AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 62. Chile AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 63. Research Process Figure 64. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-Based
  • On-Premise
Applications
  • Hospital
  • Clinic
Companies covered
  • Siemens
  • United-Imaging
  • Deepwise
  • Atrui Technology
  • Lepu Medical
  • Keya Medical
  • RaysightMed
  • Shukun Technology
  • Infervision Medical
  • Yizhun Intelligent
  • Pulse Medical
  • Fosun Aitrox
  • Edan Instruments
  • Thoth Medical
  • Nalong Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global AI Medical Imaging Software for Cardiovascular Disease Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-Based
  5. 1.2.3 On-Premise
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global AI Medical Imaging Software for Cardiovascular Disease Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Global Market Growth Prospects
  11. 1.5 Global AI Medical Imaging Software for Cardiovascular Disease Growth Trends by Region
  12. 1.5.1 Global AI Medical Imaging Software for Cardiovascular Disease Market Size by Region: 2021 VS 2025 VS 2032
  13. 1.5.2 AI Medical Imaging Software for Cardiovascular Disease Market Size by Region (2021-2026)
  14. 1.5.3 AI Medical Imaging Software for Cardiovascular Disease Market Size by Region (2027-2032)
  15. 1.6 Assumptions and Limitations
  16. 1.7 Study Goals and Objectives
  17. 1.8 Years Considered
2 Global AI Medical Imaging Software for Cardiovascular Disease Market Dynamics
  1. 2.1 AI Medical Imaging Software for Cardiovascular Disease Industry Trends
  2. 2.2 AI Medical Imaging Software for Cardiovascular Disease Industry Drivers
  3. 2.3 AI Medical Imaging Software for Cardiovascular Disease Industry Opportunities and Challenges
  4. 2.4 AI Medical Imaging Software for Cardiovascular Disease Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global AI Medical Imaging Software for Cardiovascular Disease Revenue by Company (2021-2026)
  2. 3.2 Global AI Medical Imaging Software for Cardiovascular Disease Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global AI Medical Imaging Software for Cardiovascular Disease Key Company Head office and Area Served
  4. 3.4 Global AI Medical Imaging Software for Cardiovascular Disease Company, Product Type & Application
  5. 3.5 Global AI Medical Imaging Software for Cardiovascular Disease Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global AI Medical Imaging Software for Cardiovascular Disease Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 AI Medical Imaging Software for Cardiovascular Disease Players Market Share by Revenue in 2025
  9. 3.6.3 2025 AI Medical Imaging Software for Cardiovascular Disease Tier 1, Tier 2, and Tier 3
4 AI Medical Imaging Software for Cardiovascular Disease Market by Type
  1. 4.1 Global AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2021-2032)
  3. 4.3 Global AI Medical Imaging Software for Cardiovascular Disease Market Size Share by Type (2021-2032)
5 AI Medical Imaging Software for Cardiovascular Disease Market by Application
  1. 5.1 Global AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2021-2032)
  3. 5.3 Global AI Medical Imaging Software for Cardiovascular Disease Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Siemens
  2. 6.1.1 Siemens Company Information
  3. 6.1.2 Siemens Business Overview
  4. 6.1.3 Siemens AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Siemens AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  6. 6.1.5 Siemens Recent Developments
  7. 6.2 United-Imaging
  8. 6.2.1 United-Imaging Company Information
  9. 6.2.2 United-Imaging Business Overview
  10. 6.2.3 United-Imaging AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 United-Imaging AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  12. 6.2.5 United-Imaging Recent Developments
  13. 6.3 Deepwise
  14. 6.3.1 Deepwise Company Information
  15. 6.3.2 Deepwise Business Overview
  16. 6.3.3 Deepwise AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Deepwise AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  18. 6.3.5 Deepwise Recent Developments
  19. 6.4 Atrui Technology
  20. 6.4.1 Atrui Technology Company Information
  21. 6.4.2 Atrui Technology Business Overview
  22. 6.4.3 Atrui Technology AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Atrui Technology AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  24. 6.4.5 Atrui Technology Recent Developments
  25. 6.5 Lepu Medical
  26. 6.5.1 Lepu Medical Company Information
  27. 6.5.2 Lepu Medical Business Overview
  28. 6.5.3 Lepu Medical AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Lepu Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  30. 6.5.5 Lepu Medical Recent Developments
  31. 6.6 Keya Medical
  32. 6.6.1 Keya Medical Company Information
  33. 6.6.2 Keya Medical Business Overview
  34. 6.6.3 Keya Medical AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Keya Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  36. 6.6.5 Keya Medical Recent Developments
  37. 6.7 RaysightMed
  38. 6.7.1 RaysightMed Company Information
  39. 6.7.2 RaysightMed Business Overview
  40. 6.7.3 RaysightMed AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 RaysightMed AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  42. 6.7.5 RaysightMed Recent Developments
  43. 6.8 Shukun Technology
  44. 6.8.1 Shukun Technology Company Information
  45. 6.8.2 Shukun Technology Business Overview
  46. 6.8.3 Shukun Technology AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Shukun Technology AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  48. 6.8.5 Shukun Technology Recent Developments
  49. 6.9 Infervision Medical
  50. 6.9.1 Infervision Medical Company Information
  51. 6.9.2 Infervision Medical Business Overview
  52. 6.9.3 Infervision Medical AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Infervision Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  54. 6.9.5 Infervision Medical Recent Developments
  55. 6.10 Yizhun Intelligent
  56. 6.10.1 Yizhun Intelligent Company Information
  57. 6.10.2 Yizhun Intelligent Business Overview
  58. 6.10.3 Yizhun Intelligent AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Yizhun Intelligent AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  60. 6.10.5 Yizhun Intelligent Recent Developments
  61. 6.11 Pulse Medical
  62. 6.11.1 Pulse Medical Company Information
  63. 6.11.2 Pulse Medical Business Overview
  64. 6.11.3 Pulse Medical AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Pulse Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  66. 6.11.5 Pulse Medical Recent Developments
  67. 6.12 Fosun Aitrox
  68. 6.12.1 Fosun Aitrox Company Information
  69. 6.12.2 Fosun Aitrox Business Overview
  70. 6.12.3 Fosun Aitrox AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Fosun Aitrox AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  72. 6.12.5 Fosun Aitrox Recent Developments
  73. 6.13 Edan Instruments
  74. 6.13.1 Edan Instruments Company Information
  75. 6.13.2 Edan Instruments Business Overview
  76. 6.13.3 Edan Instruments AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Edan Instruments AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  78. 6.13.5 Edan Instruments Recent Developments
  79. 6.14 Thoth Medical
  80. 6.14.1 Thoth Medical Company Information
  81. 6.14.2 Thoth Medical Business Overview
  82. 6.14.3 Thoth Medical AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Thoth Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  84. 6.14.5 Thoth Medical Recent Developments
  85. 6.15 Nalong Health
  86. 6.15.1 Nalong Health Company Information
  87. 6.15.2 Nalong Health Business Overview
  88. 6.15.3 Nalong Health AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Nalong Health AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  90. 6.15.5 Nalong Health Recent Developments
7 North America
  1. 7.1 North America AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032)
  2. 7.2 North America AI Medical Imaging Software for Cardiovascular Disease Market Size by Type
  3. 7.2.1 North America AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2021-2026)
  4. 7.2.2 North America AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2027-2032)
  5. 7.2.3 North America AI Medical Imaging Software for Cardiovascular Disease Market Share by Type (2021-2032)
  6. 7.3 North America AI Medical Imaging Software for Cardiovascular Disease Market Size by Application
  7. 7.3.1 North America AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2021-2026)
  8. 7.3.2 North America AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2027-2032)
  9. 7.3.3 North America AI Medical Imaging Software for Cardiovascular Disease Market Share by Application (2021-2032)
  10. 7.4 North America AI Medical Imaging Software for Cardiovascular Disease Market Size by Country
  11. 7.4.1 North America AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021-2026)
  13. 7.4.3 North America AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2027-2032)
  14. 7.4.4 North America AI Medical Imaging Software for Cardiovascular Disease Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032)
  2. 8.2 Europe AI Medical Imaging Software for Cardiovascular Disease Market Size by Type
  3. 8.2.1 Europe AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2021-2026)
  4. 8.2.2 Europe AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2027-2032)
  5. 8.2.3 Europe AI Medical Imaging Software for Cardiovascular Disease Market Share by Type (2021-2032)
  6. 8.3 Europe AI Medical Imaging Software for Cardiovascular Disease Market Size by Application
  7. 8.3.1 Europe AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2021-2026)
  8. 8.3.2 Europe AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2027-2032)
  9. 8.3.3 Europe AI Medical Imaging Software for Cardiovascular Disease Market Share by Application (2021-2032)
  10. 8.4 Europe AI Medical Imaging Software for Cardiovascular Disease Market Size by Country
  11. 8.4.1 Europe AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021-2026)
  13. 8.4.3 Europe AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2027-2032)
  14. 8.4.4 Europe AI Medical Imaging Software for Cardiovascular Disease Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032)
  2. 9.2 China AI Medical Imaging Software for Cardiovascular Disease Market Size by Type
  3. 9.2.1 China AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2021-2026)
  4. 9.2.2 China AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2027-2032)
  5. 9.2.3 China AI Medical Imaging Software for Cardiovascular Disease Market Share by Type (2021-2032)
  6. 9.3 China AI Medical Imaging Software for Cardiovascular Disease Market Size by Application
  7. 9.3.1 China AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2021-2026)
  8. 9.3.2 China AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2027-2032)
  9. 9.3.3 China AI Medical Imaging Software for Cardiovascular Disease Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032)
  2. 10.2 Asia AI Medical Imaging Software for Cardiovascular Disease Market Size by Type
  3. 10.2.1 Asia AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2021-2026)
  4. 10.2.2 Asia AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2027-2032)
  5. 10.2.3 Asia AI Medical Imaging Software for Cardiovascular Disease Market Share by Type (2021-2032)
  6. 10.3 Asia AI Medical Imaging Software for Cardiovascular Disease Market Size by Application
  7. 10.3.1 Asia AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2021-2026)
  8. 10.3.2 Asia AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2027-2032)
  9. 10.3.3 Asia AI Medical Imaging Software for Cardiovascular Disease Market Share by Application (2021-2032)
  10. 10.4 Asia AI Medical Imaging Software for Cardiovascular Disease Market Size by Country
  11. 10.4.1 Asia AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021-2026)
  13. 10.4.3 Asia AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2027-2032)
  14. 10.4.4 Asia AI Medical Imaging Software for Cardiovascular Disease Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size by Type
  3. 11.2.1 South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size by Application
  7. 11.3.1 South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size by Country
  11. 11.4.1 South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst